Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2809 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 2.47 USD | -3.14% | -7.14% | -29.43% | -29.02% | 538.21 M USD | ||
| 2813 |  RGNX REGENXBIO Inc. - Common Stock | 8.09 USD | +6.45% | +6.73% | -7.01% | -39.76% | 534.05 M USD | ||
| 2818 |  NGNE Neurogene Inc. - Common Stock | 26.50 USD | +2.44% | -1.67% | -30.34% | -9.93% | 530.30 M USD | ||
| 2842 |  PBYI Puma Biotechnology Inc - Common Stock | 9.97 USD | +1.63% | +0.30% | +10.78% | +90.27% | 514.65 M USD | ||
| 2848 |  ALT Altimmune, Inc. - Common Stock | 2.60 USD | -2.26% | -7.14% | -21.69% | -35.48% | 505.75 M USD | ||
| 2852 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.66 USD | +5.73% | -3.49% | -16.16% | -20.19% | 501.86 M USD | ||
| 2865 |  VALN Valneva SE - American Depositary Shares | 5.69 USD | -3.07% | -1.39% | -14.31% | -47.12% | 493.72 M USD | ||
| 2867 |  ARVN Arvinas, Inc. - Common Stock | 7.51 USD | +0.81% | 0.00% | -17.02% | -19.25% | 491.05 M USD | ||
| 2883 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 1.40 USD | -2.10% | -10.83% | -19.08% | -2.78% | 483.69 M USD | ||
| 2894 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 1.77 USD | -2.21% | -4.32% | -11.50% | 0.00% | 471.11 M USD | ||
| 2903 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 8.01 USD | -1.11% | -12.36% | -6.43% | +5.12% | 465.69 M USD | ||
| 2905 |  ASMB Assembly Biosciences, Inc. - Common Stock | 22.82 USD | -0.57% | -2.06% | -35.97% | -22.46% | 464.63 M USD | ||
| 2917 |  OVID Ovid Therapeutics Inc. - Common Stock | 2.34 USD | -0.85% | -5.26% | -12.69% | +29.28% | 457.00 M USD | ||
| 2921 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 4.56 USD | +4.59% | +9.62% | -14.45% | -50.49% | 453.48 M USD | ||
| 2931 |  SLN Silence Therapeutics Plc - American Depository Share | 9.52 USD | -3.05% | -11.61% | -28.85% | +76.30% | 449.79 M USD | ||
| 2933 |  RZLT Rezolute, Inc. - Common Stock | 4.64 USD | +5.94% | +12.35% | +15.14% | -47.33% | 448.79 M USD | ||
| 2938 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 22.75 USD | +0.18% | +0.09% | -24.62% | +32.65% | 444.75 M USD | ||
| 2944 |  PRTA Prothena Corporation plc - Ordinary Shares | 8.61 USD | +1.53% | -0.12% | -6.92% | -16.73% | 442.01 M USD | ||
| 2955 |  EDIT Editas Medicine, Inc. - Common Stock | 2.84 USD | +3.27% | +10.08% | +2.53% | -32.22% | 436.17 M USD | ||
| 2961 |  ENTX Entera Bio Ltd. - Ordinary Shares | 2.50 USD | -0.40% | -13.49% | -11.35% | 0.00% | 432.85 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |